昆明哪家医院做人流的比较好昆明那里的人流医院好,昆明做打胎需都少钱,昆明好的流产医院是那些,昆明做人流哪里医院比较好,昆明手术打胎价钱,昆明人流正规医院,昆明市比较较好的流产医院

The White House released official portraits of President Donald Trump and Vice President Mike Pence Tuesday morning.According to an official press release from the White House, the portraits were produced by the Government Publishing Office. The photos will be distributed and displayed in the offices of federal agencies across the country.The walls of federal agencies have been a bit bare since Jan. 20, when former President Barack Obama's portrait was taken down in all federal agencies following the inauguration. A September story by the Washington Post reported that the Trump administration was slow to release an official portrait — Obama's portrait was released by March of his first year in office, President Bill Clinton's was released by June.The White House also says the photographs will be made available for sale to the public.  859

The United States and Mexico have reached an agreement to change parts of NAFTA, the trade deal that President Donald Trump has derided for years as unfair.Trump announced the agreement from the Oval Office Monday, with Mexican President Enrique Pe?a Nieto dialed in on a conference call.But the deal left open the question of whether Canada, the third country in NAFTA, would agree to the changes -- and Trump himself said he wanted to throw out the name NAFTA altogether."They used to call it NAFTA," Trump said. "We're going to call it the United States-Mexico trade agreement. We're going to get rid of NAFTA because it has a bad connotation."Negotiators for both countries agreed to a new rule that dictates where auto parts are made.Under the current law, about 62 percent of the parts in any car sold in North America must be produced in the region or automakers have to pay import taxes. The new preliminary agreement would require that 75 percent of auto parts be made in the United States and Mexico, according to the U.S. Trade Representative's office.Much of the business world has been worried about Trump's trade policies, and the stock market reacted positively to the news. The Dow rose more than 250 points and the S&P 500 and Nasdaq hit new highs on Monday.The agreement between the two countries could restart negotiations on NAFTA with all three parties -- the United States, Mexico and Canada.Despite Trump's signal that the deal could lead to a bilateral trade agreement between the United States and Mexico, Pe?a Nieto, through a translator, expressed his "desire that now Canada will also be able to be incorporated in this."Mexico and Canada have stood firm on the importance of maintaining the trilateral format of the NAFTA free trade deal, even as Trump has signaled a desire for individual deals with each country."Canada is encouraged by the continued optimism shown by our negotiating partners," said a spokesperson for Canadian Minister of Foreign Affairs Chrystia Freeland."Progress between Mexico and the United States is a necessary requirement for any renewed NAFTA agreement," he said.Negotiations on rewriting the three-country NAFTA agreement began about a year ago.The 24-year-old trade agreement generally prevents the three parties from imposing tariffs on imports from one another. But Trump has called the agreement "the worst deal maybe ever signed" and moved ahead with tariffs earlier this year.In May, the United States imposed steep tariffs on steel and aluminum from much of the world, including Mexico. In response, Mexico slapped tariffs on billion of U.S. goods, including steel, pork, apples, potatoes, bourbon and different types of cheese. Canada imposed tariffs on .5 billion of U.S. goods, including steel, toffee, maple syrup, coffee beans and strawberry jam. 2841

The White House announced Friday that President Donald Trump intends to appoint Mehmet Oz, better known as Dr. Oz, to his council on sport, fitness and nutrition.Oz is well-known as a host of an eponymous television show on health and medical issues and, before that, for appearances on "The Oprah Winfey Show." But he has become a lightning rod for controversy for featuring what critics say is unscientific advice on his show.In 2015, a group of doctors criticized him harshly, saying he manifested "an egregious lack of integrity" in his TV and promotional work and called his faculty position at Columbia University unacceptable.Oz defended himself in a written statement at the time, saying, "I bring the public information that will help them on their path to be their best selves. We provide multiple points of view, including mine which is offered without conflict of interest."The-CNN-Wire 906

The US Food and Drug Administration expanded?the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.New to the list are some valsartan products manufactured by Hetero Labs Ltd. in India, which are labeled as Camber Pharmaceuticals Inc. Test results show that some of the products may be tainted.The FDA announced a valsartan recall in July after lab tests revealed that some drugs could have been tainted with a substance linked to higher risk of cancer. The drug had been recalled in 22 other countries. The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide. Not all of the drugs containing valsartan were affected.N-nitrosodimethylamine or NDMA, the impurity the lab tests found, is considered a?possible carcinogen by the US Environmental Protection Agency. It is an organic chemical that has been used to make liquid rocket fuel, and it can be unintentionally introduced through certain chemical reactions. It's a byproduct of the manufacturing of some pesticides and fish processing.The medicines that are now a part of this expanded list?in the recall are tablets sold by AvKare, A-S Medication Solutions LLC, Bryant Ranch Prepack Inc, Camber Pharmaceuticals, Inc. H J Harkins Company, Northwind Pharmaceuticals, NuCare Pharmaceuticals Inc., Prinston Pharmaceutical Inc. (labeled as Solco Healthcare LLC), Proficient Rx LP, Remedy Repack, Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis).The FDA also published a list of valsartan products that are not currently recalled. Only the drugs suspected of being tainted with NDMA are on the recall list. If you are taking a valsartan drug, look for the company name on your prescription bottle. If the information isn't on the label, you can call your pharmacy for those details.The recalled medicine is linked to a manufacturer in China. The substances were supplied by Zhejiang Huahai Pharmaceuticals, based in Linhai, in eastern China, which said it notified authorities as soon as it identified the impurity."We published our recall notice at midday on July 13 in China and overseas, and published the US market recall notice on July 14 Beijing time ... all the drug materials for the Chinese market were recalled by July 23," the company said in a statement to the Shanghai stock exchange last month.The FDA said on its website that it's working with drug manufacturers "to ensure future valsartan active pharmaceutical ingredients are not at risk."If you are worried that your drug could be on the recall list, talk with your doctor or pharmacist before changing any routine with your medicine. Because not all valsartan drugs are involved in the recall, they might be able to switch you to a version of the drug made by another company.If you know your drug is on the recall list, the FDA suggests you continue taking it until your doctor or pharmacist provides a replacement.To get a sense of what taking a tainted drug could mean, FDA scientists estimated that if 8,000 people took the highest dose of valsartan (320 milligrams) from the recalled batches every day for four years, there may be one additional case of cancer."The key with this is, patients should not stop taking their medication abruptly, that definitely can be harmful," Dr. Mary Ann Bauman, a representative for the American Heart Association, said in July. "You don't want to jump to any conclusions on your own about this medication, or any medication for that matter. Definitely talk with your doctor first." 3690

The Washington Post has settled a libel lawsuit with Kentucky high school student Nicholas Sandmann, who was at the center of a viral video controversy in 2019.Sandmann sued several news media outlets after their coverage falsely painted his as a racist, wearing a ‘Make America Great Again’ hat during an interaction with a Native American activist near the Lincoln Memorial in Washington D.C. Judge William O. Bertelsman previously dismissed the lawsuit, but later reinstated the case, after he reviewed an amended complaint.On Friday, Sandmann celebrated the settlement on Twitter. 592